TITLE

Inflammatory bowel disease—be aware of the mimics

AUTHOR(S)
Ravens, A.-F.
PUB. DATE
March 2006
SOURCE
Gut;Mar2006, Vol. 55 Issue 3, p333
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article illustrates the result of the clinical tests of a 43-year old male nurse practitioner with inflammatory bowel disease. In colonoscopy, the rectum showed swollen and aphthous ulcers with pus on them. The patient has a strong history of colon cancer presented with bloody diarrhea. Biopsies of the rectal and colonic lesions were taken.
ACCESSION #
20098083

 

Related Articles

  • New screening guidelines to reduce colorectal cancer death rates. Sibal, Meg // Filipino Reporter;5/25/2012, Vol. 40 Issue 25, p25 

    The author discusses a research study on the reduction of colorectal cancer death in polypectomy patients during colonoscopy that was published in the "New England Journal of Medicine" which analyzed 2,602 adenoma patients with benign tissue growths in the colon. She agrees that study findings...

  • PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Loflus Jr, E. V.; Harewood, G. C.; Loflus, C. G.; Tremaine, W. J.; Harmsen, W. S.; Zinsmeister, A. R.; Jewell, D. A.; Sondborn, W. J. // Gut;Jan2005, Vol. 54 Issue 1, p91 

    Background: inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD) may have a high prevalence of rectal sparing, backwash ileitis, and colorectal neoplasia. Aims: To describe the clinical features and outcomes of PSC-IBD and compare these to a group of chronic...

  • Quality Indicators for Colonoscopy. Rex, Douglas K; Schoenfeld, Philip S; Cohen, Jonathan; Pike, Irving M; Adler, Douglas G; Fennerty, M Brian; Lieb, John G; Park, Walter G; Rizk, Maged K; Sawhney, Mandeep S; Shaheen, Nicholas J; Wani, Sachin; Weinberg, David S // American Journal of Gastroenterology;Jan2015, Vol. 110 Issue 1, p72 

    The article reports on a study which describes the quality indicators for the diagnosis and treatment of colon disorders using colonoscopy. The researchers have determined the effectiveness of colonoscopy on colorectal cancer (CRC) screenings tests, postpolypectomy, and post-cancer resection...

  • Dysplasia in ulcerative colitis-clinical consequences? Sjöqvist, Urban // Langenbeck's Archives of Surgery;Oct2004, Vol. 389 Issue 5, p354 

    Background: The overall absolute risk of colorectal cancer (CRC) in longstanding extensive or total ulcerative colitis (UC) is estimated to be 10%-15%. The size of this risk is 6- to 10-times that expected in the background population. By performing complete colonoscopies with multiple biopsies...

  • Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Lutgens, M. W. M. D.; Oldenburg, B.; Siersema, P. D.; van Bodegraven, A. A.; Dijkstra, G.; Hommes, D. W.; de Jong, D. J.; Stokkers, P. C. F.; van der Woude, C. J.; Vleggaar, F. P. // British Journal of Cancer;11/17/2009, Vol. 101 Issue 10, p1671 

    Background:Colonoscopic surveillance provides the best practical means for preventing colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients. Strong evidence for improved survival from surveillance programmes is sparse.Method:The aim of this study was to compare tumour stage and...

  • Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Balzola, Federico; Bernstein, Charles; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2011, Vol. 12 Issue 2, p75 

    The article presents a study which examines the clinical characteristics and treatment in inflammatory bowel disease (IBD) patients having colorectal cancer (CRC) in Ireland. The study showed that CRC and IBD patients were a mean of 7.7 years younger compared to those without IBD at CRC...

  • Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Bernstein, Charles N.; Blanchard, James F.; Metge, Colleen; Yogendran, Marina // American Journal of Gastroenterology;Dec2003, Vol. 98 Issue 12, p2784 

    OBJECTIVES: There is increased interest in determining whether 5-aminosalicylate (5-ASA) use can prevent the development of colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD). The aim of this study was to determine whether use of 5-ASA was associated with a reduced risk...

  • Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy. von Roon, Alexander C.; Karamountzos, Leonidas; Purkayastha, Sanjay; Reese, George E.; Darzi, Ara W.; Teare, Julian P.; Paraskeva, Paraskevas; Tekkis, Paris P. // American Journal of Gastroenterology;Apr2007, Vol. 102 Issue 4, p803 

    OBJECTIVES: Fecal calprotectin (FC) is a relatively new marker of intraluminal intestinal inflammation. Using meta-analytical techniques, the study aimed to evaluate the diagnostic precision of FC for inflammatory bowel disease (IBD) and colorectal cancer (CRC) in adults and children. METHODS:...

  • RATIONALE FOR CANCER PREVENTION STRATEGIES IN HIGH-RISK ULCERATIVE COLITIS. Campbell, F. C.; Maxwell, R. J. // Surgeon (Edinburgh University Press);Apr2009, Vol. 7 Issue 2, p96 

    Colorectal cancer (CRC) is the most feared long-term complication in patients with ulcerative colitis (UC) and Crohn's colitis. Surveillance by colonoscopy and serial biopsy is conducted to identify patients most likely to benefit from potentially curative surgery. Within this paradigm, patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics